glp-1 for inflammation Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits Potential Use of GLP-1 and

10.1016/B978-0-12-386454-3.00591-1 Encyclopedia of Toxicology 24

This discrepancy in clinical recommendations underscores the critical need for comprehensive real-world evidence studies to elucidate the safety profile and adverse reaction patterns associated with combination therapy

Fadini, Dipeptidyl-peptidase 4 Inhibition: Linking Metabolic Control to Cardiovascular Protection, Curr

Semaglutide and other GLP-1 drugs can cause side effects like nausea, diarrhoea, dizziness, stomach pain, and constipation

Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats